Latest News - Atopic Dermatitis

Tuesday, January 15, 2019

New Review Highlights Comprehensive Treatment Guidelines for Severe AD

A team of investigators from the University of Colorado College of Nursing at CU Anschutz Medical Campus and National Jewish Health has identified comprehensive guidelines for managing severe atopic d…

Read the full story

Thursday, January 03, 2019

Bristol-Myers Squibb to Acquire Celgene

Bristol-Myers Squibb Company will acquire Celgene Corp. in a cash and stock transaction with an equity value of approximately $74 billion. The combined company with complementary areas of focus, will …

Read the full story

Friday, December 28, 2018

Dr. Sandra Marchese Johnson, Yoseph Dalia Win Practical Dermatology®’s Best Paper of 2018 Award

Fort Smith, Arkansas-based dermatologist Sandra Marchese Johnson MD, FAAD and Yoseph Dalia, BS took home Practical Dermatology®’s Best Paper of 2018 award for a Resident Resource Center subm…

Read the full story

Wednesday, December 12, 2018

AD, Suicidal Thoughts and Attempts Linked

Patients with eczema may be more likely to have suicidal thoughts and attempts compared to their counterparts without eczema, according to a new study in JAMA Dermatology. Researchers evaluated the…

Read the full story

Tuesday, December 11, 2018

Dermatologists Need More Info About Cannabinoids

Dermatologists are interested in learning more about cannabinoids and recommending them to patients, according to a new survey in Journal of Drugs in Dermatology. However, many are concerned a…

Read the full story

Monday, December 10, 2018

Asana Biosciences Gets Fast Track Designation from FDA for Dual JAK/SYK Inhibitor for AD

The FDA has granted Fast Track designation to Asana BioSciences’ investigational oral Janus Kinase (JAK) and Spleen Tyrosine Kinase (SYK) dual inhibitor ASN002 for the treatment of moderate-to-s…

Read the full story

Monday, November 19, 2018

Case Study: Allergy Shots May Treat Severe Eczema

Allergy shots provided significant benefits to the eczema symptoms of a 48-year-old man, according to challenging case presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annua…

Read the full story

Monday, November 19, 2018

Sonoma Pharmaceuticals Launches New Ceramax Skin Barrier Lotion

Sonoma Pharmaceuticals, Inc. has launched a new Ceramax™ Skin Barrier Lotion that complements Sonoma’s current Ceramax Skin Barrier Cream. Both Ceramax products contain skin-enriching…

Read the full story

Tuesday, November 06, 2018

US FDA Grants Dupixent Priority Review for Moderate-to-Severe AD in Adolescents

The US Food and Drug Administration (FDA) has granted Priority Review for Dupixent (dupilumab) as a potential treatment for adolescents with uncontrolled moderate-to-severe atopic dermatitis (AD). …

Read the full story

Tuesday, October 30, 2018

New AD Estimate: As Many As 16.5 Million Adults Have AD

As many as 16.5 million adults in America have atopic dermatitis (AD). This estimate comes from a new study from the Perelman School of Medicine at the University of Pennsylvania, which also projec…

Read the full story

Friday, October 05, 2018

EPI Acquires Rights to Cloderm Cream from Promius Pharma

EPI Health has acquired the rights rights to Cloderm® (clocortolone pivalate) Cream, 0.1% and its authorized generic from Promius Pharma, LLC, a wholly owned subsidiary of D…

Read the full story

Tuesday, October 02, 2018

LEO Science & Tech Hub and Epicore Biosystems to Explore Wearable Skin Sensors to Improve Dermatologic Treatment Regimens

LEO Science & Tech Hub has established a new partnership with Epicore Biosystems focused on exploring the use of a non-invasive, wearable sweat sensor to measure prognostic biomarkers in…

Read the full story

Monday, September 17, 2018

Almirall and Evotec Form Dermatology Research Collaboration

Alrimal and Evotec aim to discover and develop first-in-class therapeutics through a novel approach to disrupt cell signaling, that is expected to deliver highly potent and durable treatments for debi…

Read the full story

Friday, September 14, 2018

Inaugural World Eczema Day: GlobalSkin Launches International Movement for Eczema Sufferers

To mark the first-ever Atopic Eczema Day, the International Alliance of Dermatology Patient Organizations (IADPO -- also known as GlobalSkin) has launched AltogetherEczema, a new movement to elevate…

Read the full story

Friday, September 14, 2018

First-Ever Molecular Study Shows African American Skin Reacts Differently to AD

African Americans are known to have greater treatment challenges with atopic dermatitis than European Americans and require higher doses of some medications to get relief, and now a new study suggests…

Read the full story
Load More